Last Friday, the Covered Calls position in Bristol-Myers Squibb Company (ticker BMY) closed out-of-the-money at $59.12 which was below its $60.00 strike price. Early in this morning's trading session, Bristol-Myers' stock price advanced above the $60.00 strike price and I decided to close out the position by selling the 200 BMY shares at $60.44 per share.
As detailed below, the return-on-investment results are: +2.8% absolute return (equivalent to +57.5% annualized return-on-investment) for the 18 days of this investment.
Bristol-Myers Squibb Company (BMY) -- Covered Calls Position Closed OutThe buy/write net limit order transaction was as follows:
9/24/2026 Bought 200 Bristol-Myers Squibb Company shares at $60.95.
9/24/2026 Sold 2 BMY 10/9/2026 $60.00 Call options @ $1.57 per share. The Implied Volatility of these Calls was 21.6 when this position was established, which is above (as preferred) the current value of the S&P 500 Volatility Index (i.e. VIX) which was 15.7.
10/2/2026 Quarterly ex-dividend of $.63 per share.
10/9/20/2026 Two Bristol-Myers Call options closed out-of-the-money at $59.12, so the Call options expired and 200 BMY shares remained in the Covered Calls Advisor Portfolio.
10/12/2026 Closed out this Bristol-Myers Covered Calls position by selling the 200 shares at $60.44 per share.
The overall performance results (including commissions) for this Bristol Myers Covered Calls position are as follows:
Covered Calls Cost Basis: $11,877.34
= ($60.95 - $1.57) * 200 shares + $1.34 commission
Net Profit Components:
(a) Options Income: +$312.66
= ($1.57 * 200 shares) - $1.34 commission
(b) Dividend Income: +$126.00 = ($.63 dividend per share x 200 shares)
(c) Capital Appreciation (BMY shares sold at $60.44 per share on the Monday following the 10/9/2026 options expiration): -$102.00
+($60.44 stock selling price - $60.95 stock purchase price) * 200 shares
Total Net Profit: +$336.66
= (+$312.66 options income + $126.00 dividend income - $102.00 capital appreciation)
Absolute Return-on-Investment: +2.8%
= +$336.66/$11,877.34
Equivalent Annualized Return-on-Investment: +57.5%
= (+$336.66/$11,877.34) * (365/18 days)